Anti-Th17 Therapeutical Antibody scFv Fragment (CAT#: TAB-771CL)
Recombinant monoclonal antibody scFv Fragment expressed in E. coli binding to Th17. AZ17 is a product of ALLOZYNE's E. coli based CAESAR platform and is composed of two single chain variable antibody fragments (scFv s), and AZ17 is a novel bispecific Th17 antagonist that inhibits the differentiation and effector function of human Th17 cells in vivo. AZ17 holds the promise of superior efficacy, safety and possibly even dosing convenience over currently marketed therapies for various autoimmune diseases.
Specific Inquiry
Specifications
- Type
- scFv
- Related Disease
- Inflammatory Diseases
Product Property
- Purity
- >95% by HPLC
- Storage
- Short term: store at 4°C (over 6 months), long term: -20°C or -80°C.
Target
- Alternative Names
- Th17
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-771CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.